Clinical trials: Substance-Related Disorder
Acute Alcohol Intoxication
Assessing the Safety and Efficacy of FSD-F2R6-A-CP in Volunteers in an Induced State of Alcohol Intoxication
This will be a (2 visit) double-blind, randomized, placebo crossover design clinical study to assess the potential benefits of FSD-F2R6-A-CP versus a placebo by assessing its impact on side effect profiles as well as cognitive…
- Trial name
- METAL-2 (NCT06505239)
- Testing
- FSD-F2R6-A-CP
- Where
- United States
- Volunteers
- 26 people, healthy volunteers welcome
- Sponsor
- Quantum Biopharma
Opiate Overdose, Fentanyl Overdose
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
The purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select courts in rural and urban communities in Ohio.
- Conditions
- Opiate Overdose, Fentanyl Overdose, Harm Reduction
- Trial name
- NCT05493475
- Testing
- Fentanyl Test Strips
- Where
- United States
- Volunteers
- 653 people
- Sponsor
- Nationwide Children's Hospital
Nicotine Use Disorder
Real-time eCounselling for Nicotine Addiction
The goal of this clinical trial is to pilot an eHealth intervention (real-time telecounselling) in nicotine addiction. The main questions it aims to answer are: Is the intervention likely to be efficacious in preventing an…
- Trial name
- NCT06544057
- Testing
- CBT-MI
- Where
- United Kingdom
- Volunteers
- 60 people
- Sponsor
- Overcome
Alcohol-Related Disorders, Substance-Related Disorders
"Effectiveness of a Brief Intervention for Substances Consumption Linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): A Randomized Control Trial in Chilean Primary Care."
Alcohol and drugs consumption are among the highest risk factor for health in Chile and abroad. In Chile, harmful use of alcohol continues to be a major contributor to the burden of disease while lost years of healthy life are…
- Conditions
- Alcohol-Related Disorders, Substance-Related Disorders, Substance Abuse
- Trial name
- NCT01573416
- Testing
- ASSIST-linked brief intervention for hazardous and harmful substance use., Observation
- Where
- 30 sites in Chile
- Volunteers
- 400 people, healthy volunteers welcome
- Sponsor
- Pontificia Universidad Catolica de Chile
Substance Use Disorders
E-health Implementation (Iowa)
This research will test a technology adoption framework to increase use of the A-CHESS smartphone app. The project, based in Iowa, will compare a control condition (using a typical product training approach to software…
- Trial name
- NCT03954184
- Testing
- NIATx-TI with Product Training/On-line Support
- Where
- 49 sites in United States
- Volunteers
- 23,659 people
- Sponsor
- University of Wisconsin, Madison
Alcoholic Hepatitis
Liver Transplantation in Alcoholic Hepatitis
Patients with alcoholic hepatitis non-responsive to steroids have a poor prognosis. Recently a French-Belgian prospective study has obtained good results (acceptable survival with a low rate of alcohol recidivism).
- Trial name
- SETH-HA (NCT01768715)
- Where
- 17 sites in Spain
- Volunteers
- 40 people
- Sponsor
- Sociedad Española de Trasplante Hepático
Cocaine Dependence
Gender and Neural Substrates of Stress and Craving
Cocaine dependence is an insidious disease underscored by a powerful proclivity to relapse despite an individual's ability to recognize the deleterious consequences of continued drug use.
- Trial name
- NCT00756925
- Testing
- Acthrel
- Where
- United States
- Volunteers
- 19 people
- Sponsor
- Medical University of South Carolina
Substance-Related Disorders
Behavioral Insights to Encourage Judicious Prescribing of Opioids
In collaboration with the San Diego Medical Examiner's Office and the State of California's controlled Substance Utilization Review and Evaluation System (CURES), the investigators propose to review opioid poisonings over the…
- Trial name
- NCT02790476
- Testing
- Letters
- Where
- United States
- Volunteers
- 851 people
- Sponsor
- University of Southern California
Cannabinoid Hyperemesis Syndrome
Comparing Haloperidol to Olanzapine in the Treatment of Suspected Cannabinoid Hyperemesis in the Emergency Department
The aim of the study is to identify which medication (haloperidol or olanzapine) is most effective in treating nausea and abdominal pain associated with cannabinoid hyperemesis using a 10-point visual analog scale with intervals…
- Trial name
- CH2O (NCT07246187)
- Testing
- Olanzapine 10 milligram, Haloperidol
- Where
- United States
- Volunteers
- 31 people
- Sponsor
- Mercy Bon Secours Saint Vincent Medical Center
Opiate Dependence
ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids
This was a Phase 2, multicenter, randomized, double-blind pilot study in opioid-using adults to assess the presence, duration, and degree of opiate blockade as well as the safety and tolerability of Medisorb® naltrexone…
- Trial name
- NCT01218984
- Testing
- Medisorb naltrexone 75 mg, Medisorb naltrexone 150 mg, Medisorb naltrexone 300 mg
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- Alkermes, Inc.
Alcoholic Liver Disease
Herbal Supplements for Improvement of Liver Function in Participants With Alcoholic Liver Disease
Alcoholic liver disease represents the major health issues and it ranges from simple steatosis to cirrhosis. There is a paucity of data to support the allopathic intervention among these group of patients.
- Trial name
- NCT03503708
- Testing
- Livitol-70
- Where
- India
- Volunteers
- 40 people
- Sponsor
- Composite Interceptive Med Science
Chronic Pain, Opioid Use Disorder
Cannabidiol in Opioid Use Disorder and Chronic Pain
This is a randomized, placebo-controlled, crossover human laboratory study investigating the dose-dependent safety and acute effects of Cannabidiol (CBD) on measures of pain and opioid craving in outpatients with opioid use…
- Trial name
- NCT04587791
- Testing
- 400 mg Cannabidiol, 800 mg Cannabidiol, 1200 mg Cannabidiol
- Where
- United States
- Volunteers
- 23 people
- Sponsor
- Yale University
Opioid Use Disorder
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
This study proposes to compare a low-dose versus a high-dose buprenorphine induction scheme in 40 fentanyl using people with Opioid Use Disorder (OUD).
- Trial name
- NCT05944952
- Testing
- buprenorphine/naloxone
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Friends Research Institute, Inc.
Alcohol Abuse, Drug Abuse
Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse
Several personality factors have been shown to be associated with risk for alcohol and substance misuse, and differentiate substance abusers based on clinical profile, treatment response and susceptibility to other forms of…
- Conditions
- Alcohol Abuse, Drug Abuse, Depression, Panic Disorder
- Trial name
- Adventure (NCT00776685)
- Testing
- Personality-targeted interventions
- Where
- United Kingdom
- Volunteers
- 3,190 people, healthy volunteers welcome
- Sponsor
- King's College London
Opioid Dependence
Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder
The overall aim of this R34 proposal is to examine the feasibility, acceptability, and short-term outcomes associated with an innovative service delivery model to increase adherence to extended-release naltrexone (XR-NTX) during…
- Trial name
- NCT03447743
- Testing
- XR-NTX community location
- Where
- United States
- Volunteers
- 9 people, healthy volunteers welcome
- Sponsor
- Michele Staton
Chronic HBV Infection, Drug Withdrawal
Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage
As an alternative biomarker of intrahepatic covalently closed circular DNA(cccDNA) transcriptional activity, hepatitis B virus(HBV)RNA may evolve during long-lasting virus-host interactionsduring chronic hepatitis B viral…
- Trial name
- NCT03909191
- Testing
- serum HBV RNA
- Volunteers
- 454 people
- Sponsor
- Changhai Hospital
Healthy Control, Opioid Use Disorder
OMAR Opioid Use Disorder
The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.
- Trial name
- NCT05683184
- Testing
- [11C]OMAR
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Yale University
Bipolar Disorder, Substance Dependence
Modifying Group Therapy for Bipolar Substance Abusers - 1
The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by…
- Trial name
- NCT00227838
- Testing
- Behavior Therapy
- Where
- United States
- Volunteers
- 60 people
- Sponsor
- National Institute on Drug Abuse (NIDA)
Opioid-use Disorder
Evaluating a Novel Medication Device for Methadone Dosing
This study will evaluate whether a commercially available, secure, electronic pill box is a feasible, acceptable, and satisfactory method to manage take-home dosing of methadone for both methadone clinic patients and staff…
- Trial name
- NCT03254043
- Testing
- Take-home Dosing Procedures
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Johns Hopkins University
Nicotine Dependence, Tobacco Use Disorder
Family and Peer Influences on Nicotine Dependence in Medical Students of South Punjab
The goal of this cross-sectional observational study is to assess the impact of family functioning and peer pressure on nicotine dependence in medical students enrolled at medical colleges in South Punjab, Pakistan (both male and…
- Conditions
- Nicotine Dependence, Tobacco Use Disorder, Family Functioning, Peer Influence
- Trial name
- NCT07123389
- Where
- Pakistan
- Volunteers
- 366 people, healthy volunteers welcome
- Sponsor
- Nishtar Medical University
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.